Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

L-MIND Trial in Relapsed/Refractory DLBCL

January 30th 2020

Future Directions of CAR T Therapy in R/R DLBCL

January 30th 2020

R/R DLBCL: CAR T Therapy and Immune Checkpoint Inhibition

January 30th 2020

Safety and Efficacy of CAR T Therapy in R/R DLBCL

January 30th 2020

Use of CAR T Therapy in R/R DLBCL

January 30th 2020

Treatment Alternatives to Chemotherapy in R/R DLBCL

January 30th 2020

Management of Relapsed/Refractory DLBCL

January 30th 2020

Role of CNS Prophylaxis in DLBCL

January 30th 2020

Optimization of PET Scans and Determining Relapse in DLBCL

January 30th 2020

Comorbidities and Role of R-CHOP in DLBCL

January 30th 2020

Prognostic Factors in DLBCL

January 30th 2020

Treatment of Newly Diagnosed DLBCL

January 30th 2020

Final Thoughts From ASH 2019 on MDS

January 30th 2020

Emerging Agents in Development for MDS

January 30th 2020

Phase III MEDALIST Trial of Luspatercept for MDS

January 30th 2020

Lenalidomide in Del 5q MDS

January 30th 2020

Erythropoiesis-Stimulating Agents for Lower-Risk MDS

January 30th 2020

MDS: Low-Risk Disease Treatment Options

January 30th 2020

Iron Chelation Therapy for MDS

January 30th 2020

Thresholds for Blood Transfusions for MDS

January 30th 2020